Latest News for: in silico

Edit

Impact of a Novel Patient-Specific, Patient-Matched Bezier Parametric Curve Rod Platform on Proximal Junction Biomechanics in an in Silico Thoracolumbar Fusion Model

PR Newswire 05 Dec 2024
PJK is a well-recognized complication in spinal deformity surgery, occurring in 6% to 62% of patients with potential added treatment costs of $55,547 - $193,277  (Alvarez Reyes et al ... Thus, it's important to be conscientious in their care.
Edit

How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery

New York Observer 12 Nov 2024
in the pharmaceutical industry has placed unprecedented power in the hands of tech-driven drug discovery, raising questions about innovation, control and patient safety ... in the pharmaceutical industry has reached a fever pitch—a point of no return.
Edit

A simulation-first approach: In Silico Technologies for Medical Innovation in the Digital Era (techUK Ltd)

Public Technologies 16 Sep 2024
... Royal Academy of Engineering Introduction In Silico Methods drive scientific innovation by leveraging computer simulation instead of biological testing.
Edit

AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event

Victoria Advocate 24 Jul 2024
Announcing Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform ....
Edit

In Silico: A Healthcare Revolution (ANSYS Inc)

Public Technologies 14 Jun 2024
). The text version of this document is not available ... Disclaimer. ANSYS Inc.
Edit

Democratizing In Silico Medical Device Testing (ANSYS Inc)

Public Technologies 08 May 2024
). The text version of this document is not available ... Disclaimer. ANSYS Inc.
Edit

Form Bio Announces In Silico Assays, Enabling Gene Therapy Companies and Their Research Partners to Accelerate the Vector Discovery & Development Process

Pharmiweb 07 May 2024
"Our new In Silico Assays capability empowers vector researchers to utilize fast and inexpensive in silico screening to ensure the best possible use of every moment and dollar spent downstream on lab-based in vitro screening.".
Edit

Form Bio Announces In Silico Assays, Enabling Gene Therapy Companies and Their Research Partners to ...

ACCESSWIRE 07 May 2024
"Our new In Silico Assays capability empowers vector researchers to utilize fast and inexpensive in silico screening to ensure the best possible use of every moment and dollar spent downstream on lab-based in vitro screening."
Edit

Using In Silico Oncology to Defeat Pediatric Cancer (ANSYS Inc)

Public Technologies 26 Apr 2024
). The text version of this document is not available ... Disclaimer. ANSYS Inc.
Edit

Unlocking the future of medicine: Advancing de novo in silico drug discovery (ImmunoPrecise Antibodies Ltd)

Public Technologies 08 Apr 2024
). The text version of this document is not available ... Disclaimer ... (noodl. 116995474) .
Edit

In Silico Clinical Trials Market Report 2023-2033 - Expanded Therapeutic Areas Present Lucrative Opportunities

MENA FN 16 Feb 2024
(MENAFN - GlobeNewsWire - Nasdaq) Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market Report 2023-2033" report has been added to ResearchAndMarkets's offering. The in ... .

Most Viewed

×